The ability of chemical radiation sensitizers such as misonidazole (MISO) to potentiate certain chemotherapeutic agents has been recognized for several years. Anti-tumour agents whose activities are most effectively enhanced both in vitro and in vivo by sensitizers include cyclophosphamide, melphalan and the nitrosoureas (for review see Millar, 1982; McNally, 1982; Siemann, 1982 Siemann, , 1984 . In vitro experiments of chemopotentiation have concentrated primarily on exposing cells to the sensitizer in the absence of oxygen (usually for a period of 2-4h) prior to treatment with the chemotherapeutic agent in air. These investigations, usually referred to as "MISO pre-incubation experiments" have been performed in attempts to develop mechanisms of action for the phenomenon of chemopotentiation (Brown, 1982) . Several antitumour drugs have been investigated extensively in this manner; particularly the alkylating agent melphalan (Stratford et al., 1980; Roizin-Towle & Hall, 1981; Taylor et al., 1982) . In vitro combinations of nitrosoureas and MISO, especially those evaluating the hypoxic cell pre-incubation effects, have been far more limited (Twentyman, 1980 (Twentyman, , 1982 despite the large enhancement ratios which can be obtained when MISO is added to in vivo therapies incorporating some of the compounds in this anti-tumour agent class (McNally, 1982; Siemann, 1982 Siemann, , 1984 .
The nitrosoureas represent an important class of chemotherapeutic agents in the treatment of human malignancies, particularly brain tumours (Levin & Wilson, 1976 (Wheeler et al., 1984) . The former studies are the subject of this report.
Exponential and plateau phase 9L culture experiments (Wheeler, et al., 1983) were performed 2 and 5 days after seeding 3 x 105 cells into 100mm glass Petri dishes. Cells were exposed to MISO under aerobic or hypoxic conditions utilizing a chamber system described in detail elsewhere (Mulcahy & Dembs, 1983) . Briefly the cells were grown in specially designed glass Petri dishes consisting of a large and small compartment separated by a glass septum. Cells were plated in the large compartment while the sensitizer, at 10 x the desired concentration, was placed in the small compartment. The plates were then sealed in aluminum chambers and degassed as previously described (Mulcahy & Dembs, 1983) . To initiate MISO exposure the aluminum chambers were tilted and rotated so that the medium overlying the cells was mixed with the drug solution maintained in the small compartment of the dish. In the MISO cytotoxicity experiments the cells were exposed to various sensitizer doses at 37°C for 0-5h, then the chambers were opened and the cells trypsinized. In the sensitizer preincubation experiments 5.0 mM MISO was administered to cells for 2 h at 370C under hypoxic conditions. Then the chambers were opened, the medium removed and cells rinsed with PBS, and fresh medium containing various For comparison with exponential phase cultures, the anti-tumour activity of BCNU administered alone or in combination with MISO, also was evaluated in plateau phase 9L cells (Figure 2b ). The clonogenic cell survival curve of these plateau phase cultures had a somewhat smaller shoulder but virtually an identical final slope to that seen when exponentially growing 9L cells were treated ( Figure   2b vs Figure 2a) . MISO pretreatment was again only effective at enhancing BCNU cell kill when the cells were exposed to MISO under hypoxic conditions (A vs ol). For plateau phase cells, a combined treatment DEF of -2.5 was observed at a survival level of 10-2.
The potentiation of BCNU by MISO pretreatment was more extensive in the exponential than plateau phase cells (Figure 2a survival curves in both cases appears to be the removal of the shoulder although there is also a suggestion that MISO pretreatment may have increased the slope of the exponential component of the survival curve to a greater extent in exponential cells than in plateau phase cells. In general, the current findings are in agreement with data published previously for the alkylating agent melphalan (Stratford et al., 1980; Roizin-Towle & Hall, 1981) . Several possible mechanisms for chemopotentiation by sensitizers have been advocated (Brown, 1982; Millar, 1982; Siemann 1982 Siemann , 1984 . These include altered drug pharmacokinetics, inhibition of potentially lethal damage (PLD) repair, increased DNA crosslinks and the depletion of non-protein sulfhydryls. For the interaction between nitrosoureas and sensitizers support for the altered pharmacokinetics hypothesis is strong (Lee & Workman, 1983; Siemann, 1984) although not all results can be accounted for on the basis of alterations in nitrosourea decay (Mulcahy & Dembs, 1983; Siemann, 1984) . Inhibition of drug-induced PLD repair by MISO, a mechanism supported by in vivo investigations (Siemann & Mulcahy, 1982) , seems unlikely to be of importance in the potentiation of BCNU activity in the present studies since 9L cells exhibit no recovery from BCNU-induced PLD (Rosenblum et al., 1975) . Depletion of intracellular SH levels, while not explaining chemopotentiation entirely (Brown, 1982) , may nevertheless represent a particularly attractive mechanism for the potentiation observed when nitrosoureas and MISO are combined because both agents can act directly on the available cellular SH pool. MISO metabolism by hypoxic cells reduces intracellular SH levels by enhancing the oxidation of glutathione while BCNU inhibits the regeneration of glutathione by affecting glutathione reductase. This mechanism could explain the relationship between nitrosourea carbamoylating potential and the extent of MISO chemopotentiation observed Mulcahy & Dembs, 1983) since nitrosoureas having the highest carbamoylating activities demonstrate the greatest glutathione reductase inhibition and vice versa.
In summary, the present studies evaluated MISO potentiation of BCNU action in exponential and plateau phase 9L cells. The results indicate the removal of the shoulders on the 9L BCNU cell survival curves by MISO pretreatment under hypoxic conditions. These data support the hypothesis that chemopotentiation is at least in part an hypoxia-mediated phenomenon.
